62 results on '"de la Torre J"'
Search Results
2. Caso de tórax presentado en la Sesión General de Lectura de Casos del XXX Uongreso Nacional de la SERAM, A Coruña. Mayo 2010
- Author
-
de la Torre, J., Martel, J., Pérez Rodrigo, S., and Hernández-Muñiz, S.
- Published
- 2010
- Full Text
- View/download PDF
3. 15. Diferencias en la presentación clínica entre la endocarditis protésica precoz y la tardía, ¿realmente existen?
- Author
-
Plata, A., Reguera, J.M., Cabrera, E., Ruiz, J., Vinuesa, D., Martínez-Marcos, F.J., Lomas, J.M., Hidalgo-Tenorio, C., de la Torre, J., and de Alarcon, A.
- Published
- 2017
- Full Text
- View/download PDF
4. Trasplante hepático en pacientes con infección VIH
- Author
-
de la Mata, M., Barrera, P., Fraga, E., Montero, J.L., de la Torre, J., López-Cillero, P., Briceño, J., Solórzano, G., and Alonso, M.
- Published
- 2003
- Full Text
- View/download PDF
5. Endocarditis por Klebsiella pneumoniae productora de betalactamasas de espectro extendido
- Author
-
del Arco, A., Olalla, J., De la Torre, J., and García-Alegría, J.
- Published
- 2011
- Full Text
- View/download PDF
6. Hemorragia digestiva alta en varón homosexual con infección por el virus de la inmunodeficiencia humana
- Author
-
del Arco, A., de la Torre, J., Mérida, L., Prada, J.L., Pereda, T., Rivera, R., Olalla, J., and García Alegría, J.
- Published
- 2009
- Full Text
- View/download PDF
7. Estudio comparativo de los niveles de receptor soluble de interleucina 2 y adenosín-desaminasa en líquidos pleurales tuberculosos y de otras etiologías
- Author
-
Avilés Inglés, M.J., Contessotto, C., Ontañón, J., Muro, M., Berlinches, P., de la Torre, J., Sánchez Gascón, F., and Álvarez López, M.R.
- Published
- 1996
- Full Text
- View/download PDF
8. Vaccination trends in people with HIV infection participanting in the hospital-based survey of patients infected with HIV, 2006-2021.
- Author
-
Hernando V, Suárez L, Gutiérrez G, López JC, Navarro-Soler R, Cabello A, Sanz J, Suarez-García I, Fernández MT, Losa JE, Pérez JL, Ramos-Ruperto L, Pérez-Elías MJ, Aayuni WBCE, Cuesta M, González G, Izquierdo A, Viloria L, López I, Martínez E, Castrillejo D, Jaume Amengual MG, Belmonte MA, Arraiza A, de la Torre J, Miqueleiz E, Marcos H, Ruiz-Algueró M, Villegas T, Simón L, and Diaz A
- Subjects
- Humans, Male, Female, Cross-Sectional Studies, Adult, Middle Aged, Influenza Vaccines administration & dosage, Pneumococcal Vaccines administration & dosage, Spain epidemiology, Health Care Surveys, Young Adult, HIV Infections, Vaccination statistics & numerical data
- Abstract
Objective: To assess the trend in hepatitis A, hepatitis B, pneumococcal, tetanus and seasonal influenza vaccination in people with HIV infection and to analyse associated factors., Methods: The Hospital Survey of Patients with HIV, an annual cross-sectional study conducted on a fixed day (2006-2021), was used. Inpatients and outpatients were included. Trends in vaccination and associated factors were analysed using logistic regression., Results: A total of 8643 participants were included. Vaccination rates increased to 65.3% for hepatitis A, 83.7% for hepatitis B, 49.3% for tetanus, 68.9% for pneumococcal and 74.5% for seasonal influenza in 2021. Factors positively associated with vaccination were older age for pneumococcal and influenza vaccination; higher educational level for hepatitis A and tetanus; living in a closed institutions or prison for tetanus, pneumococcal and influenza; and having acquired HIV through sex between men for hepatitis A, B and pneumococcal. In addition, being on antiretroviral treatment and having a high CD4 count were positively associated with vaccination for all these diseases. Factors inversely associated with vaccination were being older (hepatitis A, B and tetanus), being an immigrant (tetanus and seasonal influenza) and being an injection drug user/ex-user for hepatitis A and B., Conclusions: Vaccination in people with HIV has increased in the study period. The results are in line with the recommendations in this population, although there is still room to reach the established vaccination indicators., (Copyright © 2023 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
9. Completion of the informed consent in radioguided surgery by the General Surgery and Nuclear Medicine services of a radioguided surgery unit.
- Author
-
Jiménez-Granero P, Rayo-Madrid JI, Infante-de-la-Torre JR, Serrano-Vicente J, Martínez-Esteve A, Baena-García A, Utrera-Costero A, and Juárez-Vela R
- Subjects
- Informed Consent, Hospitals, Nuclear Medicine, Surgery, Computer-Assisted
- Abstract
Objective: To identify the frequency of errors in informed consent documents in radioguided surgery in a third level hospital and to detect possible causes or factors associated with a greater risk of error., Material and Methods: Informed consent forms of a total of 369 radioguided surgery interventions, completed by the Nuclear Medicine and General Surgery services, were analyzed, and the degree of completion of the forms and its correlation with the physicians responsible, type of pathology, intervention, and waiting time were compared with the completion of consent by another specialty., Results: Errors were identified in 22 consent forms from Nuclear Medicine and 71 from General Surgery. The most common error was the absence of identification of the physician responsible (17 in Nuclear Medicine, 51 in General Surgery), and the second most common was the absence of a document (2 in Nuclear Medicine, 20 in General Surgery). There were significant differences in the errors made depending on the doctor in charge, with no significant correlation with the other variables., Conclusions: The physicians responsible were the main factor associated with a greater risk of error in the completion of informed consent forms. Further studies are needed to analyze the causal factors and possible interventions to minimize errors., (Copyright © 2023 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
10. PERCIST and Hopkins criteria and PET/CT metabolic parameters as prognostic factors in squamous head and neck cancer.
- Author
-
Baena García Á, Infante de la Torre JR, Barco Carbonero R, Cabrera Rodríguez JJ, Martínez Esteve A, Serrano Vicente J, Jiménez Granero P, Utrera Costero A, and Ignacio Rayo J
- Subjects
- Male, Humans, Prognosis, Squamous Cell Carcinoma of Head and Neck diagnostic imaging, Squamous Cell Carcinoma of Head and Neck therapy, Retrospective Studies, Fluorodeoxyglucose F18, Radiopharmaceuticals, Positron Emission Tomography Computed Tomography, Head and Neck Neoplasms diagnostic imaging, Head and Neck Neoplasms therapy
- Abstract
Aim: To assess the clinical utility of PERCIST and Hopkins criteria and changes in [
18 F]FDG PET/CT quantitative parameters as prognostic factors for progression-free survival (PFS) and cancer-specific survival (CSS) in patients with head and neck squamous cell carcinoma treated by chemoradiotherapy., Material and Methods: Forty patients (34 men) diagnosed with head and neck squamous cell carcinoma were retrospectively assessed over an interval of 8 years. PERCIST and Hopkins criteria were used to assess response to treatment. Variations in the metabolic parameters maximum SUV (ΔSUVmax), metabolic tumor volume (ΔMTV) and total lesion glycolysis (ΔTLG) between pre- and post-treatment PET/CT studies were also determined. The Cox regression model, ROC curves and the Kaplan-Meier method were used for the analysis of prognostic factors and survival curves., Results: The mean follow-up was 39.4 months, with 24 progressions and 22 deaths. Both PERCIST and Hopkins criteria and the three metabolic parameters were predictive factors in the univariate analysis and only ΔSUVmax was in the multivariate analysis. Survival analysis showed statistically significant differences in PFS and CSS curves for the five parameters considered., Conclusion: Application of PERCIST and Hopkins criteria as well as ΔSUVmax, ΔMTV and ΔTLG from PET/CT studies proved to be prognostic factors for survival in patients in our setting for treating head and neck cancer. The results may help to personalize treatment., (Copyright © 2022 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
11. Contribution of 18 F-FDG PET/CT in a patient with unexplained monocular diplopia.
- Author
-
Cobo-Rodríguez A, Moreno-Caballero M, Martínez-Esteve A, Relaño-Mesa M, Jiménez-Granero P, and Infante-de la Torre JR
- Subjects
- Diplopia, Humans, Positron-Emission Tomography, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography
- Published
- 2021
- Full Text
- View/download PDF
12. Mental health, family roles and employment status inside and outside the household in Spain.
- Author
-
Arias-de la Torre J, Molina AJ, Fernández-Villa T, Artazcoz L, and Martín V
- Subjects
- Adult, Cross-Sectional Studies, Female, Humans, Male, Prevalence, Sex Factors, Social Class, Spain epidemiology, Employment psychology, Family Characteristics, Family Relations psychology, Gender Identity, Mental Disorders epidemiology, Mental Health
- Abstract
Objective: To document the prevalence of poor mental health by gender and social class, and to analyze if poor mental health is associated with the family roles or the employment status inside and outside the household., Method: A cross-sectional study based on a representative sample of the Spanish population was carried out (n = 14,247). Mental health was evaluated using GHQ-12. Employment status, marital status, family roles (main breadwinner and the person who mainly carries out the household work) and educational level were considered as explanatory variables. Multiple logistic regression models stratified by gender and social class were fitted and adjusted odds ratios (aOR) were obtained., Results: Gender and social class differences in the prevalence of poor mental health were observed. Unemployment was associated with higher prevalence. Among men the main breadwinner role was related to poor mental health mainly in those that belong to manual classes (aOR = 1.2). Among women, mainly among nonmanual classes, these problems were associated to marital status: widowed, separated or divorced (aOR = 1.9) and to dealing with the household work by themselves (aOR = 1.9)., Conclusions: In Spain, gender and social class differences in mental health still exist. In addition, family roles and working situation, both inside and outside the household, could constitute a source of inequalities in mental health., (Copyright © 2018 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
13. Drug use, family support and related factors in university students. A cross-sectional study based on the uniHcos Project data.
- Author
-
Arias-De la Torre J, Fernández-Villa T, Molina AJ, Amezcua-Prieto C, Mateos R, Cancela JM, Delgado-Rodríguez M, Ortíz-Moncada R, Alguacil J, Almaraz A, Gómez-Acebo I, Suárez-Varela MM, Blázquez-Abellán G, Jiménez-Mejías E, Valero LF, Ayán C, Vilorio-Marqués L, Olmedo-Requena R, and Martín V
- Subjects
- Cross-Sectional Studies, Female, Humans, Male, Prevalence, Students, Universities, Family, Social Support, Substance-Related Disorders epidemiology
- Abstract
Objective: To assess the prevalence of illegal drug use in college students on any previous occasion, during the previous year and the previous month, and to analyze the relationship between illegal drug use and family support and other factors., Methods: A cross-sectional study using data from students participating in the uniHcos project (n = 3767) was conducted. The prevalence and age of onset of consumption of cannabis, non-prescription sedatives, stimulants and depressants was evaluated. Polyconsumption was also assessed. The independent variables were: family support, age, residence, and employment status. To determine the factors related to drug use multivariate logistic regression models stratified by gender were fitted., Results: Differences between men and women in prevalence of illegal drug use except non-prescription sedatives were observed. In both genders, less family support was associated with higher consumption of all drugs, except depressants, and with polyconsumption. To be studying and looking for work was related to cannabis and stimulant use and to polyconsumption among women, but only to cannabis use among men., Conclusions: These results support the notion that the start of university studies is a particularly relevant stage in the onset of illegal drug use and its prevention, and that consumption may be especially associated with family support., (Copyright © 2017 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
14. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.
- Author
-
Pérez-Molina JA, Martínez E, Blasco AJ, Arribas JR, Domingo P, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Mariño A, Miró JM, Moreno S, Negredo E, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, von Wichmann MA, and Gatell JM
- Subjects
- HIV Infections drug therapy, HIV Infections economics, Humans, Models, Economic, Spain, Acquired Immunodeficiency Syndrome drug therapy, Acquired Immunodeficiency Syndrome economics, Anti-Retroviral Agents economics, Anti-Retroviral Agents therapeutic use, Cost-Benefit Analysis, Guideline Adherence economics
- Abstract
Background: The GESIDA/National AIDS Plan expert panel recommended preferred regimens (PR), alternative regimens (AR) and other regimens (OR) for antiretroviral treatment (ART) as initial therapy in HIV-infected patients for 2018. The objective of this study was to evaluate the costs and the efficiency of initiating treatment with PR and AR., Methods: Economic assessment of costs and efficiency (cost-effectiveness) based on decision tree analyses. Effectiveness was defined as the probability of reporting a viral load <50copies/mL at week 48, in an intention-to-treat analysis. Cost of initiating treatment with an ART regimen was defined as the costs of ART and its consequences (adverse effects, changes of ART regimen, and drug-resistance studies) over the first 48 weeks. The payer perspective (National Health System) was applied considering only differential direct costs: ART (official prices), management of adverse effects, studies of resistance, and HLA B*5701 testing. The setting was Spain and the costs correspond to those of 2018. A deterministic sensitivity analysis was conducted, building three scenarios for each regimen: base case, most favourable and least favourable., Results: In the base-case scenario, the cost of initiating treatment ranges from 6788 euros for TAF/FTC/RPV (AR) to 10,649 euros for TAF/FTC+RAL (PR). The effectiveness varies from 0.82 for TAF/FTC+DRV/r (AR) to 0.91 for TAF/FTC+DTG (PR). The efficiency, in terms of cost-effectiveness, ranges from 7814 to 12,412 euros per responder at 48 weeks, for ABC/3TC/DTG (PR) and TAF/FTC+RAL (PR), respectively., Conclusion: Considering ART official prices, the most efficient regimen was ABC/3TC/DTG (PR), followed by TAF/FTC/RPV (AR) and TAF/FTC/EVG/COBI (AR)., (Copyright © 2018 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
15. Oral Candida colonization in patients with chronic periodontitis. Is there any relationship?
- Author
-
De-La-Torre J, Quindós G, Marcos-Arias C, Marichalar-Mendia X, Gainza ML, Eraso E, Acha-Sagredo A, and Aguirre-Urizar JM
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Severity of Illness Index, Candida isolation & purification, Chronic Periodontitis microbiology, Mouth microbiology
- Abstract
Background: Candida can be implicated in the pathology of chronic periodontitis., Aims: To analyze the oral Candida carriage in patients suffering from chronic periodontitis (CP) and its correlation with the severity of this condition., Methods: Microbiological samples were taken from 155 patients using the oral rinse (OR) technique and by using paper points in the periodontal pockets (GPP). These patients were divided into 3 groups: 89 patients without CP (control), 47 with moderate CP, and 19 with severe CP. Samples were cultured in a Candida chromogenic agar for Candida. Species were identified by microbiological and molecular methods., Results: Candida was isolated in the OR of 45 (50.6%), 21 (44.7%), and 11 (57.9%) patients, respectively, and in the GPP of 32 (36%), 14 (29.2%), and 10 (42.6%) patients from the control, moderate CP and severe CP groups, respectively. Candida was isolated more frequently and in a greater burden in OR than in GPP (p<0.01). Candida albicans was the most prevalent species. GPP of patients with CP had poor fungal biodiversity (p<0.01)., Conclusions: Colonization by Candida was present in the samples of patients without CP, and with both moderate and severe CP. Nonetheless, patients with severe CP had a higher rate of Candida colonization, especially by C. albicans., (Copyright © 2018 Asociación Española de Micología. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
16. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
- Author
-
Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Asensi V, Crespo M, Domingo P, Iribarren JA, Lázaro P, López-Aldeguer J, Lozano F, Martínez E, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, and Gatell JM
- Subjects
- Adult, Humans, Practice Guidelines as Topic, Spain, Anti-Retroviral Agents economics, Anti-Retroviral Agents therapeutic use, Cost-Benefit Analysis, HIV Infections drug therapy
- Abstract
Introduction: GESIDA and the Spanish National AIDS Plan panel of experts have recommended preferred (PR), alternative (AR) and other regimens (OR) for antiretroviral therapy (ART) as initial therapy in HIV-infected patients for 2017. The objective of this study was to evaluate the costs and the efficiency of initiating treatment with PR and AR., Methods: Economic assessment of costs and efficiency (cost-efficacy) based on decision tree analyses. Efficacy was defined as the probability of reporting a viral load <50copies/mL at week 48, in an intention-to-treat analysis. Cost of initiating treatment with an ART regimen was defined as the costs of ART and its consequences (adverse effects, changes of ART regimen and drug resistance studies) during the first 48 weeks. The payer perspective (National Health System) was applied considering only differential direct costs: ART (official prices), management of adverse effects, resistance studies and HLA B*5701 screening. The setting was Spain and the costs correspond to those of 2017. A deterministic sensitivity analysis was conducted, building three scenarios for each regimen: base case, most favourable and least favourable., Results: In the base case scenario, the cost of initiating treatment ranged from 6882 euro for TFV/FTC/RPV (AR) to 10,904 euros for TFV/FTC+RAL (PR). The efficacy varied from 0.82 for TFV/FTC+DRV/p (AR) to 0.92 for TAF/FTC/EVG/COBI (PR). The efficiency, in terms of cost-efficacy, ranged from 7923 to 12,765 euros per responder at 48 weeks, for ABC/3TC/DTG (PR) and TFV/FTC+RAL (PR), respectively., Conclusion: Considering ART official prices, the most efficient regimen was ABC/3TC/DTG (PR), followed by TFV/FTC/RPV (AR) and TAF/FTC/EVG/COBI (PR)., (Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
17. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
- Author
-
Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Crespo M, Domingo P, Estrada V, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, de la Torre J, Tuset M, and Gatell JM
- Subjects
- Humans, Practice Guidelines as Topic, Spain, Anti-HIV Agents economics, Anti-HIV Agents therapeutic use, Cost-Benefit Analysis, HIV Infections drug therapy, HIV Infections economics
- Abstract
Introduction: GESIDA and the AIDS National Plan panel of experts suggest preferred (PR), alternative (AR), and other regimens (OR) for antiretroviral treatment (ART) as initial therapy in HIV-infected patients for the year 2016. The objective of this study is to evaluate the costs and the efficacy of initiating treatment with these regimens., Methods: Economic assessment of costs and efficiency (cost/efficacy) based on decision tree analyses. Efficacy was defined as the probability of reporting a viral load <50copies/mL at week 48 in an intention-to-treat analysis. Cost of initiating treatment with an ART regimen was defined as the costs of ART and its consequences (adverse effects, changes of ART regimen, and drug resistance studies) during the first 48 weeks. The payer perspective (National Health System) was applied, only taking into account differential direct costs: ART (official prices), management of adverse effects, studies of resistance, and HLA B*5701 testing. The setting is Spain and the costs correspond to those of 2016. A sensitivity deterministic analysis was conducted, building three scenarios for each regimen: base case, most favourable, and least favourable., Results: In the base case scenario, the cost of initiating treatment ranges from 4663 Euros for 3TC+LPV/r (OR) to 10,894 Euros for TDF/FTC+RAL (PR). The efficacy varies from 0.66 for ABC/3TC+ATV/r (AR) and ABC/3TC+LPV/r (OR), to 0.89 for TDF/FTC+DTG (PR) and TDF/FTC/EVG/COBI (AR). The efficiency, in terms of cost/efficacy, ranges from 5280 to 12,836 Euros per responder at 48 weeks, for 3TC+LPV/r (OR), and RAL+DRV/r (OR), respectively., Conclusion: Despite the overall most efficient regimen being 3TC+LPV/r (OR), among the PR and AR, the most efficient regimen was ABC/3TC/DTG (PR). Among the AR regimes, the most efficient was TDF/FTC/RPV., (Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
18. Inequalities in mental health in the working population of Spain: a National Health Survey-based study.
- Author
-
Arias-de la Torre J, Artazcoz L, Molina AJ, Fernández-Villa T, and Martín V
- Subjects
- Cross-Sectional Studies, Employment statistics & numerical data, Female, Health Surveys, Healthcare Disparities, Humans, Male, Mental Disorders psychology, Mental Health, Prevalence, Sex Distribution, Sex Factors, Socioeconomic Factors, Spain epidemiology, Employment psychology, Mental Disorders epidemiology
- Abstract
Objective: In the working population, poor mental health is a significant problem whose prevalence rates and associated factors could differ by gender, especially in a period of socioeconomic changes. The aims of this study were: a) to determine the prevalence of poor mental health in the working population of Spain in 2011; b) to identify the association of this prevalence with socioeconomic and work-related variables for men and women separately; c) to determine if the patterns differ by gender., Methods: A cross-sectional study was conducted with data from the National Health Survey of Spain (2011). Of the 21,007 participants in the survey, we selected 7396 whose employment status was described as "working" The General Health Questionnaire (GHQ-12) was used as a screening tool to detect poor mental health. Prevalences were calculated and bivariate and multivariate logistic regression models were fitted to verify the association between variables., Results: The prevalence of poor mental health was higher among women (19.9%) than men (13.9%), the overall prevalence being 16.8%. The variables associated with a higher prevalence were type of contract and work-related variables in men, and age and socioeconomic variables in women., Conclusions: This study shows that, in the working population of Spain, the prevalence of poor mental health and its related factors differ by gender. Poor mental health is mainly related to socioeconomic variables in women but is mostly associated with work-related variables in men., (Copyright © 2016 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
19. Contribution of brain perfusion SPECT in the diagnosis of a case of cerebral malaria.
- Author
-
Moreno-Caballero M, García Bernardo L, Domínguez Grande ML, Infante de la Torre JR, Serrano Vicente J, Fernández Prudencio L, and Rayo Madrid JI
- Subjects
- Humans, Male, Middle Aged, Malaria, Cerebral diagnostic imaging, Perfusion Imaging, Tomography, Emission-Computed, Single-Photon methods
- Abstract
Cerebral malaria is a serious complication of infection with Plasmodium falciparum. Its pathophysiological mechanisms and clinical manifestations are still currently being studied. Structural imaging techniques such as CT and MRI provide non-specific information during the diagnostic process. However, there are hardly any references on the use and potential benefits of radioisotope procedures for this pathology. In this article we present the case of a patient diagnosed with cerebral malaria treated in our centre, subjected to progressive monitoring using SPECT perfusion., (Copyright © 2016 Elsevier España, S.L.U. and SEMNIM. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
20. [Pulmonary hypertension in human immunodeficiency virus-infected patients: the role of antiretroviral therapy].
- Author
-
Olalla J, Urdiales D, Pombo M, del Arco A, de la Torre J, and Prada JL
- Subjects
- Adenine administration & dosage, Adenine analogs & derivatives, Adenine therapeutic use, Adult, Anti-HIV Agents adverse effects, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Cross-Sectional Studies, Drug Therapy, Combination, Female, HIV Infections drug therapy, Humans, Hypertension, Pulmonary chemically induced, Hypertension, Pulmonary diagnostic imaging, Hypertension, Pulmonary epidemiology, Lamivudine administration & dosage, Lamivudine adverse effects, Lamivudine therapeutic use, Male, Middle Aged, Organophosphonates administration & dosage, Organophosphonates therapeutic use, Prevalence, Retrospective Studies, Reverse Transcriptase Inhibitors administration & dosage, Reverse Transcriptase Inhibitors therapeutic use, Tenofovir, Tricuspid Valve Insufficiency complications, Ultrasonography, Anti-HIV Agents therapeutic use, HIV Infections complications, Hypertension, Pulmonary complications, Reverse Transcriptase Inhibitors adverse effects
- Abstract
Background and Objective: Pulmonary arterial hypertension (PAH) is a serious disorder, more prevalent in patients infected with human immunodeficiency virus (HIV). It is not entirely clear what role is played by highly active antiretroviral therapy (HAART) in PAH development or course. Our aim was to describe PAH prevalence in a series of HIV-infected patients and identify possible links with cumulative and current use of different antiretrovirals., Patients and Method: Cross-sectional study of a cohort of HIV-infected patients attending a hospital in southern Spain. Demographic data, data on HIV infection status and on cumulative and recent antiretroviral treatment were recorded. Transthoracic echocardiography was performed in all study participants. PAH was defined as pulmonary artery systolic pressure of 36mmHg or more., Results: A total of 400 patients participated in the study; 178 presented with tricuspid regurgitation and 22 of these presented with PAH (5.5%). No differences were encountered in age, sex, CD4 lymphocytes, proportion of naive patients or patients with AIDS. No differences were encountered in cumulative use of antiretrovirals. However, recent use of lamivudine was associated with a greater presence of PAH, whereas recent use of tenofovir and emtricitabine was associated with a lower presence of PAH. Logistic regression analysis was performed including the use of lamivudine, emtricitabine and tenofovir. Only recent use of tenofovir was associated with a lower presence of PAH (odds ratio 0.31; 95% confidence interval: 0.17-0.84)., Conclusions: PAH prevalence in our study was similar to others series. Current use of tenofovir may be associated with lower PAH prevalence., (Copyright © 2012 Elsevier España, S.L. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
21. Left ventricular mass in HIV-infected patients.
- Author
-
Olalla J, Pombo M, Del Arco A, de la Torre J, Urdiales D, and García-Alegría J
- Subjects
- Antiretroviral Therapy, Highly Active adverse effects, Cross-Sectional Studies, Female, HIV Infections drug therapy, Humans, Male, Middle Aged, HIV Infections complications, Hypertrophy, Left Ventricular etiology
- Abstract
Background: The HIV infection has been associated with an increased incidence of vascular events. Left ventricular mass (LVM) is independently associated with greater overall mortality. Various studies have shown that patients with HIV infection have higher LVM than the uninfected population. We aim to describe the distribution of LVM in an extensive series of patients with HIV infection, and the factors associated with its increase., Patients and Methods: A cross-sectional study was performed in HIV-infected patients followed in our center from 1 December 2009 to 28 February 2011. A transthoracic echocardiography (TTE) was performed in all patients who gave their consent. Demographic variables, viroimmunological status, cardiovascular risk factors, vascular risk at 10 years (VR10) and history of exposure to antiretroviral drugs were collected. LVM was considered to be the quantitative dependent variable. A univariate analysis was performed, including in the multivariate analysis those variables with P<,05., Results: A TTE was performed in 400 patients, and the LVM was calculated in 388. Mean age was 45 years, 75.5 males. Mean LVM was 39.54g/m(2.7)(95% CI: 38.35-40.73). Age, height, body mass index, VR10, hypertension, dyslipidemia, different medications within the cardiovascular area and having taken nevirapine have been used in the history of the patient were associated to greater LVM. In the multivariate analysis, use of nevirapine in the history of the patient and VR10 remained in the model., Conclusions: VR10 may be associated with greater LVM. The relationship with nevirapine may respond to an indication bias., (Copyright © 2012 Elsevier España, S.L. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
22. Seroprevalence of antibodies to the influenza A (H1N1) virus among healthcare workers prior to the 2009 pandemic peak.
- Author
-
Olalla J, de Ory F, Casas I, Del Arco A, Montiel N, Rivas-Ruiz F, de la Torre J, Prada JL, Fernández F, and García-Alegría J
- Subjects
- Adult, Cross-Sectional Studies, Female, Humans, Male, Pandemics, Seroepidemiologic Studies, Antibodies, Viral blood, Health Personnel, Influenza A Virus, H1N1 Subtype immunology, Influenza, Human blood, Influenza, Human epidemiology
- Abstract
Objective: Our aim was to study the proportion of healthcare workers with a positive serology for Influenza A(H1N1)2009 without having flu, in a Spanish hospital at the beginning of the pandemic., Methods: A survey study carried out during August 2009 (before the peak of the pandemic in Spain) in the Hospital Costa del Sol, a second level hospital with almost 300 beds in the South of Spain. The participants were workers in the following hospital units: Emergencies, Medical Area (Internal Medicine, Chest Diseases), Surgical Area (General Surgery and Anaesthesia) of any professional category. A study was made of the proportion of healthcare workers in our hospital with positive serology for the new influenza A (H1N1)2009 virus, as determined by the haemagglutination inhibition technique (≥1/40). The subjects completed a health status questionnaire, and provided a blood sample for serology testing., Results: A total of 239 workers participated, of whom 25.1% had positive serology. The hospital area in which most individuals had positive serology was the Emergency Department (36.6%), while the professional category in which most individuals with a positive serology worked was that of the orderlies (41.7%)., Conclusion: Around 25% of healthcare workers in our hospital had positive serology before the peak of the pandemic, none of them had received vaccine for Influenza A (H1N1) 2009 or had been diagnosed of influenza previously., (Copyright © 2011 Elsevier España, S.L. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
23. [Pretibial brown tumors as first manifestation of primary hyperparathyroidism].
- Author
-
Mora-Escudero I, Gato-Díez A, Blázquez-Cabrera JA, Lozano-Setien E, and García-de-la-Torre JP
- Subjects
- Humans, Male, Middle Aged, Bone Neoplasms etiology, Hyperparathyroidism, Primary complications, Hyperparathyroidism, Primary diagnosis, Tibia
- Published
- 2012
- Full Text
- View/download PDF
24. [Raltegravir in HIV-infected patients with high vascular risk].
- Author
-
Olalla J, Del Arco A, de la Torre J, Salas D, Prada JL, and García-Alegría J
- Subjects
- Aged, Antiretroviral Therapy, Highly Active, Cardiovascular Diseases blood, Cardiovascular Diseases etiology, Case-Control Studies, Cholesterol, HDL blood, HIV Infections blood, HIV Infections complications, Humans, Middle Aged, Raltegravir Potassium, Retrospective Studies, Risk, Treatment Outcome, Triglycerides blood, Cardiovascular Diseases prevention & control, HIV Infections drug therapy, HIV Integrase Inhibitors therapeutic use, Pyrrolidinones therapeutic use
- Abstract
Objectives: To record the experience with use of raltegravir (RTG) for devising highly active antiretroviral therapy (HAART) regimens based on RTG in high vascular risk patients., Methods: A retrospective study was conducted on high vascular risk patients taking RTG. Case was a patient who, at the time raltegravir was started, had ≥ 20% 10-year risk of cardiovascular disease, estimated by the algorithm of the European AIDS Clinical Society. Patients should have been on stable HAART including RTG for at least six months. A matched control with ≥ 20% risk of cardiovascular disease, was selected for each case., Results: Ten controls and ten cases were selected. After six months using RTG, a significant decreased was seen in levels of HDL cholesterol (median -2,5mg/dL in controls versus 2,5mg/dL in cases, p=0.015), triglycerides (10mg/dL versus -101 mg/dL, p=0.009), and TC/HDL-C ratio (0.17 versus -0.73, p=0.002). Ten-year risk of cardiovascular disease was -4.85% in cases versus -0.05% in controls (p=0.07)., Conclusions: RTG shows a good profile to be used in people with high vascular risk, with a decrease in TC/HDL-C ratio and vascular risk., (Copyright © 2010 Elsevier España, S.L. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
25. Coexistence of two different types of lymphoma in a patient with Sjögren's syndrome. The usefulness of the PET-CT.
- Author
-
Infante De La Torre JR, Durán Barquero C, García Bernardo L, Groiss J, Rayo Madrid JI, Serrano Vicente J, Domínguez Grande ML, and Sánchez Sánchez R
- Subjects
- Female, Humans, Lymphoma, Follicular complications, Lymphoma, Large B-Cell, Diffuse complications, Middle Aged, Neoplasms, Multiple Primary complications, Sjogren's Syndrome complications, Lymphoma, Follicular diagnostic imaging, Lymphoma, Large B-Cell, Diffuse diagnostic imaging, Multimodal Imaging, Neoplasms, Multiple Primary diagnostic imaging, Positron-Emission Tomography, Tomography, X-Ray Computed
- Abstract
Sjögren syndrome is a chronic systemic autoimmune disease in which there is an increased risk of developing non-Hodgkin's lymphoma. Neoplastic lung involvement and the coexistence of different histological types of lymphoma are uncommon in these patients. These patients frequently have associated infectious processes, most of them due to oral candidiasis. When there is immunodeficiency, the hematogenous spread of the fungus may affect the lungs. We present the case of a female patient diagnosed with follicular non- Hodgkin lymphoma within the context of long-term Sjögren syndrome. In addition to the neoplastic nodal and splenic disease, the PET-CT study showed extensive lung involvement. Due to suspicion of a false positive result for pulmonary Candida infection, antifungal treatment was initiated, with no response. A further histological study showed the presence of a second and different type of lymphoma., (Copyright © 2011 Elsevier España, S.L. and SEMNIM. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
26. [Protective role of antiretroviral treatment in the impairment of renal function in a cohort of human immunodeficiency virus patients].
- Author
-
Mérida L, de la Torre J, Olalla J, Noureddine M, del Arco A, Prada JL, Aguilar A, and García-Alegría J
- Subjects
- Adult, Anti-HIV Agents pharmacology, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Cross-Sectional Studies, Didanosine adverse effects, Didanosine therapeutic use, Female, Glomerular Filtration Rate drug effects, HIV Infections physiopathology, Humans, Kidney drug effects, Kidney Diseases etiology, Male, Middle Aged, Prospective Studies, Viral Load, Anti-HIV Agents therapeutic use, HIV Infections drug therapy, Kidney physiopathology, Kidney Diseases prevention & control
- Abstract
Background and Objective: To assess changes in renal function in a cohort of patients infected with the human immunodeficiency virus (HIV) and describe which factors are associated with deterioration., Patients and Methods: This was a prospective transversal study. The follow-up period was 12 months. Data were collected at baseline and one year including the glomerular filtration rate (GFR). We analyzed epidemiological data, comorbidities, CD4 lymphocytes, viral load, and AIDS status., Results: A total of 365 patients. Three hundred and thirteen (85%) were under highly active antiretroviral therapy (HAART); the median CD4 was 606 ± 314 and the CV was undetectable in 85%. At 1-year, we found a mean deterioration in the GFR of 9.7 ml/h. Eighty patients (21.8%) had a fall in GFR > 10 ml/h, while in 20 patients (5.8%) it was > 30 ml/h. An association was found regarding age, treatment with didanosine (DDI) and males (OR 1.89 95% CI 1.3 to 4.08, OR 2.3 95% CI 1.9 to 23 and OR 3.47 95% CI 1.6 to 14.20 respectively). We found a protective role of being under HAART (OR 0.54, 95% CI, 0.25 to 0.8)., Conclusions: There was a protective role of HAART in the deterioration of GFR of patients with HIV infection. Male gender, age and use of DDI were associated with worsening renal function. Tenofovir and protease inhibitors were not associated with further deterioration of renal function., (Copyright © 2010 Elsevier España, S.L. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
27. [Left-sided endocarditis due to gram-negative bacilli: epidemiology and clinical characteristics].
- Author
-
Noureddine M, de la Torre J, Ivanova R, Martínez FJ, Lomas JM, Plata A, Gálvez J, Reguera JM, Ruiz J, Hidalgo C, Luque R, García-López MV, and de Alarcón A
- Subjects
- Acute Kidney Injury etiology, Anti-Bacterial Agents therapeutic use, Combined Modality Therapy, Comorbidity, Cross Infection epidemiology, Cross Infection microbiology, Diabetes Complications epidemiology, Diabetes Complications microbiology, Endocarditis, Bacterial complications, Endocarditis, Bacterial drug therapy, Endocarditis, Bacterial microbiology, Endocarditis, Bacterial surgery, Gram-Negative Bacterial Infections drug therapy, Gram-Negative Bacterial Infections microbiology, Gram-Negative Bacterial Infections surgery, Heart Failure etiology, Heart Valve Diseases epidemiology, Heart Valve Diseases surgery, Heart Valve Prosthesis Implantation, Humans, Liver Cirrhosis epidemiology, Neoplasms epidemiology, Prospective Studies, Spain epidemiology, Ventricular Dysfunction, Left etiology, Endocarditis, Bacterial epidemiology, Gram-Negative Bacterial Infections epidemiology
- Abstract
Introduction: The aim of this study is to describe the epidemiological, clinical characteristics, and outcome of patients with left-side endocarditis caused by gram-negative bacteria., Method: Prospective multicenter study of left-sided infective endocarditis reported in the Andalusian Cohort for the Study of Cardiovascular Infections between 1984 and 2008., Results: Among the 961 endocarditis, 24 (2.5%) were caused by gram-negative bacilli. The most common pathogens were Escherichia coli, Pseudomonas aeruginosa and Salmonella enterica. Native valves (85.7%) were mainly affected, most of them with previous valve damage (57%). Comorbidity was greater (90% vs 39%; P=.05) than in endocarditis due to other microorganism, the most frequent being, diabetes, hepatic cirrhosis and neoplasm. A previous manipulation was found in 47.6% of the cases, and 37% were considered hospital-acquired. Renal failure (41%), central nervous system involvement (33%) and ventricular dysfunction (45%) were the most frequent complications. Five cases (21%) required cardiac surgery, mostly due to ventricular dysfunction. More than 50% of cases were treated with aminoglycosides, but this did not lead to a better outcome or prognosis. Mortality (10 patients) was higher than that reported with other microorganisms (41% vs 35%; P=.05)., Conclusions: Left-sided endocarditis due to gram-negative bacilli is a rare disease, which affects patients with major morbidities and often with a previous history of hospital manipulations. Cardiac, neurological and renal complications are frequent and associated with a high mortality. The association of aminoglycosides in the antimicrobial treatment did not involve a better outcome or prognosis., (Copyright © 2010 Elsevier España, S.L. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
28. Comparison of CHOP treatment with specific short-intensive chemotherapy in AIDS-related Burkitt's lymphoma or leukemia.
- Author
-
Xicoy B, Ribera JM, Miralles P, La Cruz J, Oriol A, Valencia E, Morgades M, Mahillo B, de la Torre J, Téllez MJ, Brunet S, Esteve J, and Hoelzer D
- Subjects
- Adult, Aged, Cyclophosphamide, Doxorubicin, Female, Humans, Male, Middle Aged, Prednisone, Retrospective Studies, Vincristine, Young Adult, Antineoplastic Combined Chemotherapy Protocols, Burkitt Lymphoma drug therapy, Lymphoma, AIDS-Related drug therapy
- Abstract
Background and Objective: AIDS-related Burkitt's lymphoma or leukemia (BLL) is increasingly treated with specific and intensive multiagent schedules. This retrospective study aimed to compare the results of CHOP with those from two protocols (PETHEMA-LAL3/97 and BURKIMAB) of specific therapy in Spain., Patients and Methods: Patients from Group A (n=31) received 6 standard CHOP cycles every 3 weeks. Patients from group B (n=44) received six multiagent cycles including high-dose methotrexate and high-dose cytarabine. The response to therapy, disease-free survival and overall survival (OS) were compared in the two groups., Results: Both groups were comparable for the main clinical and biological parameters at diagnosis except for risk activity, previous HAART, bone marrow involvement, bulky disease and extranodal involved sites. Complete remission (CR) was achieved in 10 out of 31 (32%) patients in group A and 28 out of 44 (67%) patients in group B (P=.005). After a median (range) follow-up of 70 (26-139) and 17 (1-134) months, the 5-year (95% CI) DFS probability was 87% (64%-100%) for group A and 70% (51%-89%) for group B (P=.374), and the 5-year (95% CI) OS was 27% (10%-43%) for Group A and 57% (40%-74%) for group B (P=.028). Multivariate analyses showed that specific therapy was associated with an improved CR and OS., Conclusions: In AIDS-related BLL short intensive specific chemotherapy is feasible, with higher remission rate and improved survival than that obtained with CHOP-based regimens., (Copyright © 2010 Elsevier España, S.L. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
29. Update on bacteraemia in oncology and hematology.
- Author
-
Fortún J, Sanz MÁ, Madero L, López J, de la Torre J, Jarque I, and Vallejo C
- Subjects
- Drug Resistance, Multiple, Bacterial, Hematologic Diseases complications, Humans, Immunocompromised Host, Neoplasms complications, Bacteremia complications, Bacteremia drug therapy, Bacteremia epidemiology, Bacteremia microbiology, Bacteremia prevention & control, Hematology trends, Medical Oncology trends
- Abstract
The present article is an update of the literature on bacteraemia in onco-hematologic patients. A multidisciplinary group of Spanish physicians with an interest in this field selected the most important papers published recently. Papers from the fields of basic science, epidemiology, causative microorganisms and clinical syndromes are discussed. Important aspects of these studies include the assessment of different strategies in the management of fever in neutropenic patients and the validation of specific scores. Moreover, early identification of patients at risk of bacterial and of multi-drug resistant infections is a topic of increasing interest., (Copyright © 2011 Elsevier España S.L. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
30. [Thoracic imaging case presented at the General Case Reading Session of the XXX National Congress of the SERAM, A Coruña. May 2010].
- Author
-
de la Torre J, Martel J, Pérez Rodrigo S, and Hernández-Muñiz S
- Subjects
- Adult, Humans, Male, Radiography, Birt-Hogg-Dube Syndrome diagnostic imaging
- Published
- 2010
- Full Text
- View/download PDF
31. [Factors associated with an abnormal ankle-braquial index in a cohort of patients with HIV-1 infection].
- Author
-
Salas D, Olalla J, Del Arco A, De La Torre J, Prada JL, Pombo M, García-Alegría J, and Martos F
- Subjects
- Adult, Cohort Studies, Confidence Intervals, Data Interpretation, Statistical, Female, HIV Infections drug therapy, Humans, Logistic Models, Male, Middle Aged, Protease Inhibitors therapeutic use, Risk Factors, Ankle Brachial Index, HIV Infections epidemiology, HIV-1
- Abstract
Introduction and Objectives: An abnormal ankle-braquial index (ABI) has been related to a higher vascular mortality in the general population. People with HIV infection have a higher prevalence of abnormal ABI than general population. Our aim was to study that prevalence in a cohort of patients with HIV chronic infection and associated factors with an abnormal ABI., Methods: ABI was calculated consecutively in all the patients who agreed to participate. Abnormal ABI was defined as that lower than 0.9 or higher than 1.3. Demographic variables and those related to vascular risk, HIV infection status and antiretroviral therapy were assessed., Results: 231 patients collaborated in the study, and 25% of them had abnormal ABI (<0.9 in only 3 patients). Age, hypertension, lipid lowering agents use, vascular risk using Framingham equation, proportion of AIDS, CD4 nadir, years with the infection and protease inhibitors use were greater in the group with abnormal ABI. In logistic regression, lipid lowering agents use (OR: 0.39, CI95%: 0.16-0.94) and protease inhibitors use (OR: 2.59, CI95%: 1.33-5.05) remained in the model., Conclusion: Protease inhibitors use is associated with abnormal ABI, overall with an ABI greater than 1.3., (Copyright © 2010 Elsevier España, S.L. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
32. [Radioguided surgery of intestinal carcinoid tumor relapse. Role of SPECT-CT].
- Author
-
Serrano Vicente J, Domínguez Grande ML, Infante De La Torre JR, Duran Barquero C, Garcia Bernardo L, Rayo Madrid JI, Pérez Andrés I, and Sánchez Sánchez R
- Subjects
- Humans, Male, Middle Aged, Carcinoid Tumor diagnosis, Carcinoid Tumor surgery, Intestinal Neoplasms diagnosis, Intestinal Neoplasms surgery, Neoplasm Recurrence, Local diagnosis, Neoplasm Recurrence, Local surgery, Surgery, Computer-Assisted, Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed
- Abstract
We present a patient with clinical suspicion of intestinal carcinoid relapse confirmed by a somatostatin receptor scintigraphy. A very intense somatostatin avid abdominal lesion was located and radioguided surgery was proposed. Prior to the procedure, we performed a SPECT-CT that made it possible to detect and localize the lesion anatomically, thus facilitating the performance of the radioguided procedure. Furthermore, it modified the planning of the intervention with the adequate physical and human resources to prevent the possible surgical complications., (Copyright © 2010 Elsevier España, S.L. y SEMNIM. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
33. [Inguinal herniation of a bladder diverticulum, diagnosed by PET-CT].
- Author
-
Durán Barquero C, Serrano Vicente J, García Bernardo L, Domínguez Grande ML, Rayo Madrid JI, Infante de la Torre JR, and Sánchez Sánchez R
- Subjects
- Aged, Diagnosis, Differential, Diverticulum diagnostic imaging, Hernia, Inguinal etiology, Humans, Lymph Nodes diagnostic imaging, Lymphoma, Non-Hodgkin diagnostic imaging, Male, Urinary Bladder Diseases diagnostic imaging, Diverticulum complications, Hernia, Inguinal diagnostic imaging, Positron-Emission Tomography, Tomography, X-Ray Computed, Urinary Bladder Diseases complications
- Published
- 2010
- Full Text
- View/download PDF
34. [Optimization of sentinel lymph node biopsy in breast cancer by intraoperative axillary palpation].
- Author
-
Serrano Vicente J, Infante de la Torre JR, Domínguez Grande ML, García Bernardo L, Durán Barquero C, Rayo Madrid JI, Sánchez Sánchez R, Correa Antúnez MI, Amaya Lozano JL, and Conde Martín AF
- Subjects
- Adenocarcinoma diagnostic imaging, Adenocarcinoma pathology, Adenocarcinoma surgery, Axilla, False Negative Reactions, Female, Humans, Lymphatic Metastasis diagnostic imaging, Lymphatic Metastasis pathology, Mastectomy, Radionuclide Imaging, Radiopharmaceuticals pharmacokinetics, Retrospective Studies, Adenocarcinoma secondary, Breast Neoplasms surgery, Lymph Node Excision, Lymphatic Metastasis diagnosis, Palpation methods, Sentinel Lymph Node Biopsy methods
- Abstract
Introduction: Sentinel node biopsy (SNB) by radioisotopes is a widely accepted and reliable surgical method for staging breast cancer in patients with unknown positive axillary lymph nodes involvement. The main limitation of this method is due to the appearance of false negatives that may be caused by tumor lymph node blockage of the sentinel lymph node and uptake in the neighboring lymph nodes. Infiltered sentinel nodes are generally increased in size and firm. Thus, they can be detected by intraoperative palpation, even when there is no uptake by the radiotracer., Aim: To reduce the false negative rates by applying intraoperative axillary palpation after SNB., Method: Over a two-year period, we complemented the SNB in 168 patients with careful intraoperative axillary palpation, detecting and removing all the palpable suspicious lymph nodes (SLN) that were analyzed as sentinel nodes, Results: In 32 out of 168 patients, 50 palpable SLN were found. In 3 out of 32 patients, 4 infiltrated SLNs were demonstrated with negative SNB and positive axillary lymphadenectomy. Thus, intraoperative palpation avoided false negative results. In one patient, one palpable SLN with tumor involvement was observed and SNB was also positive. In the remaining 28 patients, the histological analysis of 45 SLN was negative for tumor but SNB was positive in 3 patients., Conclusion: Intraoperative axillary palpation, once the SNB was done, reduced the false negative rate. Thus, we consider that it should be included as one more part of this procedure., (Copyright 2009 Elsevier España, S.L. y SEMNIM. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
35. [Restless legs syndrome: detection, diagnosis, impact on health and utilization of health care resources].
- Author
-
Baos Vicente V, Grandas Pérez F, Kulisevsky Bojarski J, Lahuerta Dal-Ré J, Luquin Piudo R, Cummings Donadio P, Delgado Nicolás MA, Ibáñez Bernabéu V, Iglesias Rodal M, Jover Blanca A, Muñoz Rodríguez A, Navarro Pérez J, Palancar de la Torre JL, and Sanfélix Genovés J
- Subjects
- Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Delivery of Health Care statistics & numerical data, Female, Humans, Male, Middle Aged, Quality of Life, Retrospective Studies, Surveys and Questionnaires, Young Adult, Restless Legs Syndrome complications, Restless Legs Syndrome diagnosis
- Abstract
Introduction: Despite the high prevalence of Restless Legs Syndrome (RLS) reported, little information is available about this disorder in Spain. The present study was conducted to obtain information on this condition from patients identified by a simple screening questionnaire and subsequent diagnostic confirmation by the Primary Care Practitioner (PCP)., Materials and Methods: Three-stage, cross-sectional and retrospective (resource utilization), observational study in a sample of adult patients (2,047 subject) attending 10 outpatient Primary Care centers in Madrid, Barcelona and Valencia. A screening questionnaire containing the 4 RLS diagnostic criteria was used. Clinical assessment and RLS diagnosis confirmation was performed using a structured questionnaire. Other variables assessed were quality of life by SF-36 questionnaire scoring; sleep by the MOS sleep scale; symptom severity of RLS symptoms by the IRLS scales; health care resource utilization in the previous 12 months by completion of questionnaire following patient chart review. The diagnosis made by the PCP was confirmed in a small sample of patients by a neurologist expert in Movement Disorders., Results: A total of 19.7% (404 out of 2,047) subjects positively answered the 4 diagnostic questions of the RLS screening questionnaire. Of these, 185 (9.0%) reported moderate to severe symptoms at least twice weekly. The PCP made a diagnosis of RLS in 79 of 154 patients completing the diagnostic interview. Thus, prevalence of RLS estimated in this adult population was 4.6%. The predictive value of the screening RLS questionnaire was 51.3%. Average age of symptom onset was 42 years (range: 20 - over 80 years). RLS symptoms were moderately (50.6%) or extremely (38%) distressing and 73.4% of RLS patients slept poorly at least two nights a week. This diagnosis represents 9.4% of all patients presenting to PCP and experiencing poor sleep. Mean score in the IRLS scale (0 - 40) was 19.4. Average score of SF-36 questionnaire (0-100) was 54.6, lower than the Spanish general reference population (61.4). About one third of the RLS patients had seen a physician because of RLS symptoms. However, a diagnosis was made in only 48% of these and only 5% the diagnosis was RLS., Conclusions: The DECODE RLS - Spain study shows that many patients with classical RLS symptoms frequently see their PCP without being adequately diagnosed and treated. Screening tools such as that used in this study may contribute to the detection of these patients.
- Published
- 2009
- Full Text
- View/download PDF
36. [Negative predictive value of SPECT with I123 ioflupane in movement disorders (reply)].
- Author
-
Serrano Vicente J, García Bernardo L, Durán Barquero C, Constantino Silva A, Infante de la Torre JR, Domínguez Grande ML, Rayo Madrid JI, Sánchez Sánchez R, and Durán Herrera C
- Subjects
- Humans, Predictive Value of Tests, Iodine Radioisotopes, Movement Disorders diagnostic imaging, Nortropanes, Tomography, Emission-Computed, Single-Photon
- Published
- 2009
- Full Text
- View/download PDF
37. [Upper digestive bleeding in homosexual male with human immunodeficiency virus infection].
- Author
-
Del Arco A, de la Torre J, Mérida L, Prada JL, Pereda T, Rivera R, Olalla J, and García Alegría J
- Subjects
- Homosexuality, Male, Humans, Male, Middle Aged, Sarcoma, Kaposi pathology, Skin Neoplasms pathology, Gastrointestinal Hemorrhage etiology, HIV Infections complications, Sarcoma, Kaposi etiology, Skin Neoplasms etiology
- Published
- 2009
- Full Text
- View/download PDF
38. [Negative predictive value of (123)I Ioflupane SPECT in movement disorders].
- Author
-
Serrano Vicente J, García Bernardo L, Durán Barquero C, Constantino Silva A, Infante de la Torre JR, Domínguez Grande ML, Rayo Madrid JI, Sánchez Sánchez R, and Durán Herrera C
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Neurodegenerative Diseases diagnostic imaging, Parkinson Disease diagnostic imaging, Predictive Value of Tests, Retrospective Studies, Young Adult, Iodine Radioisotopes, Movement Disorders diagnostic imaging, Nortropanes, Radiopharmaceuticals, Tomography, Emission-Computed, Single-Photon
- Abstract
Objective: A non-degenerative etiology is supported by a normal SPI [normal SPECT with 123I-Ioflupane (SPI)] in a patient with movement disorders (MD)., Method: A total of 196 SPIs were conducted during the period of 2004/05. Of these, 44 were selected in order to rule out degenerative MD (DMD), the results being normal in these patients. The clinical background of these patients were reviewed in a minimum period of 24 months (range 24-40), collecting the diagnoses reached by the neurology specialists. The SPI were evaluated using a consensus, according to subjective criteria and quantification., Results: Thirty-six of the 44 patients (81%) were identified at 2 years of having nondegenerative movement disorders: 18 as essential tremor, 5 as drug-induced disorder, 4 as vascular disease, 3 as peripheral polyneuropathy, 2 postural tremors, 1 writer's cramp, 1 psychogenic tremor, 1 intercranial hypertension and 1 fibromyalgia. The remaining 8 patients were diagnosed with Parkinson's disease in 5 cases, 1 corticobasal degeneration, 1 multisystemic atrophy and another degenerative Parkinsonism with unclear etiology., Conclusion: The SPI in our hospital has a lower negative predictive value than the data reported in the literature. The false negatives could be explained because most of our patients come from neurologist physicians who are not movement disorder experts. In addition, a small proportion of degenerative Parkinsonism could evolve with normal SPI.
- Published
- 2009
39. [First antiretroviral therapy regimen in HIV-infected patients. Durability and factors associated with therapy changes].
- Author
-
de la Torre J, Santos J, Perea-Milla E, Pérez I, Moreno F, Palacios R, Santamaría S, Del Arco A, Nuño E, Godoy M, Prada JL, Olalla J, Aguilar J, and Martos F
- Subjects
- Adult, Aged, Anti-HIV Agents adverse effects, Comorbidity, Disease Management, Female, HIV Infections epidemiology, HIV Protease Inhibitors adverse effects, HIV Protease Inhibitors therapeutic use, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Retrospective Studies, Reverse Transcriptase Inhibitors adverse effects, Reverse Transcriptase Inhibitors therapeutic use, Spain epidemiology, Time Factors, Anti-HIV Agents therapeutic use, Antiretroviral Therapy, Highly Active adverse effects, HIV Infections drug therapy
- Abstract
Aim: To analyze the durability of the first highly active antiretroviral therapy (HAART) regimen used in naïve HIV-infected patients and the factors leading to therapy changes., Methods: Multicenter, retrospective study of naïve HIV-infected patients from 5 hospitals in Málaga (southeast Spain), who started HAART between January 1997 and December 2003. The main outcome measure was median time to the first change in the antiretroviral regimen. A descriptive analysis was performed and Kaplan-Meier curves were used to assess durability of the first HAART used. Independent factors associated with durability were evaluated with a Cox multiple regression model., Results: A total of 603 patients started HAART, and 130 (21.6%) remained under the same treatment at the latest evaluation point. Median time on the same HAART was 17.5 months, and reached 24 months when cases of simplification or structured intermittent treatment interruption were excluded from the analysis. HAART had been interrupted in 36% by one-year of follow-up. Toxicity was the main cause of switching therapy (25%), followed by simplification (19%), and virologic failure (15%). Longer durability of HAART was observed in non-nucleoside reverse transcriptase inhibitor (NNRTI) regimens, (P < 0.046; HR, 1.58) and in those with less than 5 pills (P < 0.001; HR, 2.05)., Conclusion: Median durability of the first HAART was almost one year and a half, and discontinuation was mainly due to toxicity. NNRTI regimens showed longer durability, which could be attributable to a lower pill burden, at least in part.
- Published
- 2008
- Full Text
- View/download PDF
40. [Left-sided native valve endocarditis by coagulase-negative staphylococci: an emerging disease].
- Author
-
Haro JL, Lomas JM, Plata A, Ruiz J, Gálvez J, de la Torre J, Hidalgo-Tenorio C, Reguera JM, Márquez M, Martínez-Marcos F, and de Alarcón A
- Subjects
- Aged, Female, Heart Valve Diseases diagnosis, Heart Valve Diseases epidemiology, Heart Valve Diseases therapy, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Endocarditis, Bacterial diagnosis, Endocarditis, Bacterial epidemiology, Endocarditis, Bacterial therapy, Heart Valve Diseases microbiology, Staphylococcal Infections diagnosis, Staphylococcal Infections epidemiology, Staphylococcal Infections therapy
- Abstract
Objectives: To describe the epidemiological, clinical, and prognostic characteristics of patients with left-sided native valve endocarditis (LNVE) caused by coagulase-negative staphylococci (CoNS)., Patients and Method: Prospective multicenter study of endocarditis cases reported in the Andalusian Cohort for the Study of Cardiovascular Infections between 1984 and 2005., Results: Among 470 cases of LNVE, 39 (8.3%) were caused by CoNS, a number indicating a 30% increase in the incidence of this infection over the last decade. The mean age of affected patients was 58.32 +/- 15 years and 27 (69.2%) were men. Twenty-one patients (53.8%) had previous known valve disease and half the episodes were considered nosocomial (90% of them from vascular procedures). Median time interval from the onset of symptoms to diagnosis was 14 days (range: 1-120). Renal failure (21 cases, 53.8%), intracardiac damage (11 cases, 28.2%), and central nervous system involvement (10 cases, 25.6%) were the most frequent complications. There were only 3 cases (7.7%) of septic shock. Surgery was performed in 18 patients (46.2%). Nine patients (23.1%) died, overall. Factors associated with higher mortality in the univariate analysis were acute renal failure (P = 0.023), left-sided ventricular failure (P = 0.047), and time prior to diagnosis less than 21 days (P = 0.018). As compared to LNVE due to other microorganisms, the patients were older (P = 0.018), had experienced previous nosocomial manipulation as the source of bacteremia (P < 0.001), and developed acute renal failure more frequently (P = 0.001). Mortality of LNVE due to CoNS was lower than mortality in Staphylococcus aureus infection, but higher than in Streptococcus viridans infection., Conclusions: Left-sided native valve endocarditis due to CoNS is now increasing because of the ageing of the population. This implies more frequent invasive procedures (mainly vascular) as a consequence of the concomitant disease. Nonetheless, the mortality associated with LNVE due to CoNS does not seem to be greater than infection caused by other pathogens.
- Published
- 2008
- Full Text
- View/download PDF
41. [Prevalence of primary resistance mutations in patients with newly diagnosed HIV infection in the province of Málaga (Spain)].
- Author
-
Palacios R, Viciana I, Pérez de Pedro I, de la Torre J, Ropero F, Fernández S, Salgado F, Roldán J, de Dios Colmenero J, Márquez M, and Santos J
- Subjects
- Female, HIV Infections virology, Humans, Male, Prospective Studies, Spain, Drug Resistance, Viral, HIV Infections drug therapy, HIV-1 drug effects, HIV-1 genetics, Mutation
- Abstract
Introduction: The reported prevalence of primary resistance mutations differs between studies. An analysis was performed to determine the prevalence of primary resistance mutations and HIV subtypes in our area., Methods: Prospective study performed in all patients diagnosed with HIV in the year 2005 in the province of Malaga (Spain). Plasma samples from these patients were tested for genotypic resistance (TruGene HIV-1 genotyping kit; Bayer Healthcare Diagnostics) and HIV subtype., Results: A total of 172 cases were diagnosed, 6 of them recent seroconvertors. Genotype resistance testing disclosed resistance mutations in 7.8% (95% CI 3.5-12.0%) of 153 patients in which it was performed (6 to NNRTIs, 4 to NRTIs, and 3 to PIs). HIV subtype was B in 81.8% of patients, and non-B in 18.1% (51.8% of them of sub-Saharan origin, in whom the prevalence of this subtype was 73.6%). Among European patients, only those from Spain presented the non-B subtype (prevalence 7.4%). The only factor related with the presence of resistance mutations was seroconversion (OR 9.2; 95% CI 1.3-61.9; P < .02)., Conclusions: There was a considerable prevalence of primary resistance mutations in patients with newly diagnosed HIV infection in Malaga province, with seroconversion being the only related factor. The high prevalence of the non-B HIV subtype in the Spanish population is noteworthy. Genotype resistance testing is recommendable in all newly diagnosed HIV patients in our area.
- Published
- 2008
- Full Text
- View/download PDF
42. [Liver transplantation in patients with HIV infection].
- Author
-
de la Mata M, Barrera P, Fraga E, Montero JL, de la Torre J, López-Cillero P, Briceño J, Solórzano G, and Alonso M
- Subjects
- Clinical Trials as Topic, HIV Infections therapy, Humans, Liver Failure surgery, Liver Transplantation ethics, Patient Selection, Socioeconomic Factors, HIV Infections complications, HIV-1, Liver Failure complications, Liver Transplantation standards
- Published
- 2004
- Full Text
- View/download PDF
43. [Immunological, virological and clinical response in patients infected with HIV after highly active antiviral therapy with nelfinavir: prospective cohort study].
- Author
-
de Alarcón A, Viciana P, Lozano F, Vergara A, Pujol E, Barrera A, Pérez-Guzmán E, Colmenero MA, Hernández-Quero J, Márquez M, de la Torre J, Aliaga L, Suárez I, Gutiérrez-Ravé V, Torres-Tortosa M, Marín J, Valdayo MJ, and Milla M
- Subjects
- Adult, Aged, Cohort Studies, Female, Follow-Up Studies, HIV Infections immunology, HIV Infections virology, Humans, Male, Middle Aged, Prospective Studies, Antiretroviral Therapy, Highly Active, HIV Infections drug therapy, HIV Protease Inhibitors therapeutic use, Nelfinavir therapeutic use
- Abstract
Introduction: To assess the long-term effectiveness, safety and response-related factors in a cohort of HIV-infected persons receiving antiretroviral therapy containing nelfinavir. Design and setting. Prospective, non-randomized multicenter study., Method: A total of 792 patients were included: 254 (32.1%) treatment-naive patients and 538 (67.9%) patients previously treated with protease inhibitors who were switched to a nelfinavir-containing regimen due to virological failure or intolerance. Factors related to virological response and to treatment failure were assessed by standard survival techniques and Cox proportional risk models., Results: Nelfinavir was well tolerated; treatment had to be interrupted in only 57 patients (7.1%) because of toxicity. During a median follow-up of 12 months, 31 patients (3.9%) experienced a new AIDS-defining event or death, and 463 (58.4%) showed immunological response. Overall, 52% patients achieved plasma HIV-1 RNA levels below 500 copies/mL (57% of naive and 49% of previously treated patients), but a high rate of virological rebound (24% and 49%, respectively) was observed. Low baseline viral load and few prior treatments were factors related to virological response. Naive treatment status and a high increase in CD4 cell count were predictive of longer viral response., Conclusions: Highly active antiretroviral therapy with a nelfinavir-containing regimen was associated with favorable virological response in nearly half of previously treated patients, and most experienced clinical and immunological benefits. Nevertheless, the limited duration of virological response indicates the need for new alternative drugs.
- Published
- 2003
44. [Desensitization to fluconazole in patient with human inmunodeficiency virus infection].
- Author
-
Del Arco A, Prada JL, de La Torre J, and Romualdo L
- Subjects
- Adult, Drug Resistance, Fungal, Humans, Male, Antifungal Agents therapeutic use, Cryptococcosis complications, Cryptococcosis drug therapy, Fluconazole therapeutic use, HIV Infections complications
- Published
- 2002
- Full Text
- View/download PDF
45. [Primary testicular lymphoma. Report of a case].
- Author
-
Piedra Lara JD, Capitán Manjón C, Cruceyra Betriu G, Tejido Sánchez A, García de la Torre JP, and Leiva Galvis O
- Subjects
- Humans, Male, Middle Aged, Leukemia, Lymphocytic, Chronic, B-Cell surgery, Testicular Neoplasms surgery
- Abstract
Case report of a primary testicular lymphoma in a sixty-two years old man, presenting initially as an enlargement of the testicle as the only symptom. Orchiectomy of left testicle was performed, with the diagnosis of Non-Hodgkin B lymphocytic lymphoma. The treatment applied was CHOP, presenting poor evolution with cerebral metastasis. He dead twenty-five months later diagnosis.
- Published
- 2002
- Full Text
- View/download PDF
46. [Lumbar tumor in a patient with AIDS].
- Author
-
Moreno J, Rivero A, Vidal E, Castón JJ, Natera C, de La Torre J, and Kindelán JM
- Subjects
- Adult, Aspergillosis complications, Humans, Kidney Diseases complications, Kidney Diseases microbiology, Male, Acquired Immunodeficiency Syndrome complications, Aspergillosis diagnosis, Aspergillus niger, Kidney Diseases diagnosis
- Published
- 2002
- Full Text
- View/download PDF
47. [Leydig cell tumor: report of 8 cases and review of the literature].
- Author
-
Cruceyra Betriu G, Tejido Sánchez A, Duarte Ojeda JM, García De La Torre JP, De La Morena Gallego JM, Martínez Silva V, and Leiva Galvis O
- Subjects
- Adult, Child, Humans, Male, Middle Aged, Leydig Cell Tumor diagnosis, Testicular Neoplasms diagnosis
- Abstract
Leydig cell tumor is the most frequent non-germ cell tumors of testis, included in the group of specialized gonadal stromal neoplasms. It has a low incidence, accounting for 1-3% of testicular neoplasms. This tumor is characterized by its endocrine manifestations, due to the tumor's capacity to secrete hormones. We report eight cases, including the description of their clinical, diagnosis and therapeutic features, as well as their follow-up. We also make a review of the literature about this rare testicular tumor.
- Published
- 2002
- Full Text
- View/download PDF
48. [Use of levofloxacine in primary care for outbreaks in COPD].
- Author
-
de Dios del Valle R, Hernández Sánchez A, Franco Vidal A, and Palancar de la Torre JL
- Subjects
- Amoxicillin-Potassium Clavulanate Combination therapeutic use, Cefuroxime therapeutic use, Cephalosporins therapeutic use, Evidence-Based Medicine, Humans, Randomized Controlled Trials as Topic, Anti-Infective Agents therapeutic use, Ofloxacin therapeutic use
- Abstract
Objective: To find scientific evidence to support the indication for treating outbreaks in COPD patients on an out-patient basis with levofloxacine, as against conventional treatments., Design: Standardised review, following the criteria of medicine based on the evidence. A bibliographic search of the MEDLINE data base from 1966 to June 2000 was the basis for an analysis of the evidence found., Setting: Non-hospital treatment., Patients and Other Participants: COPD patients suffering a light outbreak of probable bacterial origin, according to the Anthonisen criteria., Interventions: The intervention analysed was treatment with 500 mg/day of levofloxacine taken orally. An attempt was made to compare this with conventional treatments such as amoxycillin-clavulanic acid and acetyl cefuroxime. The indicators of results analysed were reduction in mortality or in the number of hospital admissions., Measurements and Main Results: No clinical trial was found that compared levofloxacine and amoxycillin-clavulanic acid. Two clinical trials were found that compared levofloxacine and acetyl cefuroxime. These found no significant differences between the group treated with levofloxacine and the group treated with cefuroxime., Conclusions: No scientific evidence demonstrating advantages of levofloxacine treatment over amoxycillin-clavulanic acid was found, or over acetyl cefuroxime as empirical PC first-choice treatment for patients with outbreaks of COPD.
- Published
- 2001
- Full Text
- View/download PDF
49. [Pulmonary embolism in a patient with Q fever. Are the anticardiolipin antibodies the origin?].
- Author
-
del Arco A, de La Torre J, Luís Prada J, and García J
- Subjects
- Adult, Humans, Pulmonary Embolism immunology, Q Fever immunology, Antibodies, Anticardiolipin analysis, Pulmonary Embolism etiology, Q Fever complications
- Published
- 2001
- Full Text
- View/download PDF
50. [Alteration in the biodistribution of 99mTc-albumin microspheres after its administration through a canalized umbilical vein].
- Author
-
Pacheco Capote C, Vallejo Casas JA, Torres Avisbal M, González FM, Infante de la Torre JR, Arias Blanco C, and Latre Romero JM
- Subjects
- Albumins administration & dosage, Biological Availability, Catheterization, Female, Humans, Infant, Newborn, Injections, Intravenous, Lung diagnostic imaging, Lung metabolism, Microspheres, Radionuclide Imaging, Technetium administration & dosage, Lung abnormalities, Technetium pharmacokinetics, Umbilical Veins
- Abstract
We present the case of a newborn female patient with a suspected right hypoplastic lung who was referred to our Service to perform a perfusion lung scintigraphy. The tracer (99mTc-albumin microspheres) was injected with a central catheter through the umbilical vein. The lung scan showed abnormal extrapulmonary activity that was attributed to an erroneous canalization (catheter in Arantius duct). A new study, with injection through the peripheral vein, showed the lung perfusion, with a global decrease of activity in the right lung. This case demonstrates a cause of abnormal extrapulmonary perfusion tracer uptake, verifying that using the correct access route is mandatory.
- Published
- 2000
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.